MedPath

Management of Allergic Rhinitis through Ayurveda

Phase 2/3
Not yet recruiting
Conditions
Allergic rhinitis, unspecified. Ayurveda Condition: PRATISYAYAH/PINASAH,
Registration Number
CTRI/2023/05/053020
Lead Sponsor
Dr Himanshi
Brief Summary

The increasing prevalence of Allergic Rhinitis globally is a matter of concern. Worldwide, allergic rhinitis affects between 10% to 30% of the population. Worldwide sensitization (IgE antibodies) to foreign protiens in the environment is present in upto 40% of the population. About 20-30% of Indian population suffer from at least one allergic disease where allergic rhinitis alone constitutes about 55% of all allergies. This region of Haryana is Semi-arid & dusty. Allergic Rhinitis is quite common in this area. Patients of Vataja Pratishyaya(Allergic Rhinitis) after having treatment from various Many treatment modalities are explained in Allopathic science like Corticosteroids, Anti-Allergic drugs, Inhalers, Antihistamines etc. but none of them are totally effective in curing the disease as well as preventing its recurrence, more over they have their own side effects like Rhinitis medicamentosa, fungal growth due to Topical steroids etc. . Hence there is a need for more effective, safe, treatment modality which is especially  beneficial in chronic cases to treat this problem from grass root level. Nasya Karma is considered as the main Shodhana therapy to expel Doshas from the Shira. Both Bringhan and Rechan Nasya are very beneficial for removing the Doshas from the body especially in chronic cases as the Doshas are lodged in different parts of Urdhavjatru. Moreover, in Vataja Pratishyaya, as there is Vimarga gamana of Vata Dosha, Panchlavan Ghrit Nasya with Vachadi Potli Ghranam does Shira shodhana and Vata Anulomana and hence it can be beneficial in this disease. In order to promote Shamana effect, Goghrit is selected for internal administration in patients suffering from Vataja Pratishyaya (Allergic Rhinitis). Hence this study entitled “A Randomized Comparative Clinical Evaluation on the Role of Panchlavan Ghrit Nasya and Vachadi Potli Ghranam with or without Internal Goghritpan in Vataja Pratishyaya (Allergic Rhinitis)†is selected for providing a better relief without any recurrence and in order to find an effective solution to the above problem for curing the disease from its root cause.

For this study total 60 patients will be taken, 30 in each group. First group will be given Panchlavan Ghrit Nasya and Vachadi Potli Ghranam with internal Goghritpa( 10-20 ml, Twice a day) administration for 30 days and other group will be given Panchlavan Ghrit Nasya and Vachadi Potli Ghranam without administration of internal Goghritpan for 30 days period, after that three follow ups will be done at 50th, 60th and 90th day and changes will be noted.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 1.Patients presenting with signs and symptoms of Vataja Pratishyaya mentioned in Ayurvedic Classics and Allergic Rhinitis according to Allopathic science.
  • 2.Patients willing to participate in the study.
  • 3.Patient of either sex.
Exclusion Criteria
  • 1.Patients having history of systemic disease as Diabetes Mellitus, Hypertension, Hypothyroidism.
  • 2.Patients suffering from gross deviation of nasal septum, nasal tumours, adenoid hyperplasia, nasal polyps etc.
  • 3.Pregnant women.
  • 4.Patients not fit for Nasya therapy and Ghritpana.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in the symptoms like Sneezing, Rhinorrhea, Stuffiness of nose90 days
Secondary Outcome Measures
NameTimeMethod
To See change in AEC, ESR levelsTo decrease the grade of severity of disease

Trial Locations

Locations (1)

Shri Krishna Government Ayurvedic College and Hospital, Kurukshetra

🇮🇳

Kurukshetra, HARYANA, India

Shri Krishna Government Ayurvedic College and Hospital, Kurukshetra
🇮🇳Kurukshetra, HARYANA, India
DrHimanshi
Principal investigator
8571911535
drhimanshi97@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.